Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · IEX Real-Time Price · USD
152.33
+2.02 (1.34%)
May 3, 2024, 4:00 PM EDT - Market closed
Alnylam Pharmaceuticals Employees
Alnylam Pharmaceuticals had 2,100 employees on December 31, 2023. The number of employees increased by 98 or 4.90% compared to the previous year.
Employees
2,100
Change (1Y)
98
Growth (1Y)
4.90%
Revenue / Employee
$953,969
Profits / Employee
-$158,131
Market Cap
19.27B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,100 | 98 | 4.90% |
Dec 31, 2022 | 2,002 | 337 | 20.24% |
Dec 31, 2021 | 1,665 | 212 | 14.59% |
Dec 31, 2020 | 1,453 | 130 | 9.83% |
Dec 31, 2019 | 1,323 | 258 | 24.23% |
Dec 31, 2018 | 1,065 | 316 | 42.19% |
Dec 31, 2017 | 749 | 235 | 45.72% |
Dec 31, 2016 | 514 | 145 | 39.30% |
Dec 31, 2015 | 369 | 113 | 44.14% |
Dec 31, 2014 | 256 | 91 | 55.15% |
Dec 31, 2013 | 165 | 36 | 27.91% |
Dec 31, 2012 | 129 | 13 | 11.21% |
Dec 31, 2011 | 116 | -56 | -32.56% |
Dec 31, 2010 | 172 | -6 | -3.37% |
Dec 31, 2009 | 178 | 8 | 4.71% |
Dec 31, 2008 | 170 | 41 | 31.78% |
Dec 31, 2007 | 129 | 7 | 5.74% |
Dec 31, 2006 | 122 | 28 | 29.79% |
Dec 31, 2005 | 94 | 23 | 32.39% |
Dec 31, 2004 | 71 | 11 | 18.33% |
Dec 31, 2003 | 60 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Baxter International | 60,000 |
Align Technology | 21,610 |
Molina Healthcare | 18,000 |
STERIS | 17,100 |
The Cooper Companies | 15,000 |
Illumina | 13,360 |
Waters | 7,900 |
Hologic | 6,990 |
ALNY News
- 4 days ago - Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity - Business Wire
- 6 days ago - Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia - PRNewsWire
- 18 days ago - Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results - Business Wire
- 18 days ago - ALNY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alnylam Pharmaceuticals, Inc. - Accesswire
- 19 days ago - Levi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNY - Accesswire
- 25 days ago - Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALNY - Accesswire
- 26 days ago - ALNY STOCK ALERT: Levi & Korsinsky Notifies Alnylam Pharmaceuticals, Inc. Investors of an Ongoing Investigation - Accesswire
- 4 weeks ago - Did Alnylam Pharmaceuticals, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ALNY - Accesswire